Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12227-12240

  Perales, Celia ^a,b   Henry, Michel ^c   Domingo, Esteban ^a,b   Wain Hobson, Simon ^c   Vartanian, Jean Pierre ^c  

^a CSIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; DOUBLE STRANDED DNA; RIBAVIRIN; RNA POLYMERASE; URACIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; GENE AMPLIFICATION; LETHAL MUTAGENESIS; MELTING POINT; MOLECULAR CLONING; MUTAGENESIS; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPECIES EXTINCTION; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSITION INTO ERROR CATASTROPHE;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CRICETINAE; DNA REPLICATION; DRUG RESISTANCE, VIRAL; FOOT-AND-MOUTH DISEASE VIRUS; GENES, LETHAL; GENOME, VIRAL; KIDNEY; MUTAGENESIS; MUTATION; MUTATION RATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; RNA, VIRAL; VIRUS REPLICATION;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 81255200497     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00716-11     Document Type: Article

References (78)

1. Agudo, R., et al. 2010. A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog. 6:e1001072.
2. Airaksinen, A., N. Pariente, L. Menendez-Arias, and E. Domingo. 2003. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311:339-349.
3. Alves, D., and J. F. Fontanari. 1998. Error threshold in finite populations. Phys. Rev. E 57:7008-7013.
4. Anderson, J. P., R. Daifuku, and L. A. Loeb. 2004. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58:183-205.
5. Arias, A., et al. 2008. Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J. Virol. 82:12346-12355.
6. Baccam, P., R. J. Thompson, O. Fedrigo, S. Carpenter, and J. L. Cornette. 2001. PAQ: partition analysis of quasispecies. Bioinformatics 17:16-22.
7. Biebricher, C. K., and M. Eigen. 2005. The error threshold. Virus Res. 107:117-127.
8. Bull, J. J., R. Sanjuan, and C. O. Wilke. 2007. Theory of lethal mutagenesis for viruses. J. Virol. 81:2930-2939.
9. Castro, C., J. J. Arnold, and C. E. Cameron. 2005. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 107:141-149.
10. Crowder, S., and K. Kirkegaard. 2005. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nature Genet. 37:701-709.
11. Cubero, M., et al. 2008. Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient. Virology 370:237-245.
12. de la Torre, J. C., and J. J. Holland. 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64:6278-6281.
13. Domingo, E., et al. 2006. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299:51-82.
14. Domingo, E., (ed.). 2005. Virus entry into error catastrophe as a new antiviral strategy. Virus Res. 107:115-228.
15. Domingo, E., C. Biebricher, M. Eigen, and J. J. Holland. 2001. Quasispecies and RNA virus evolution: principles and consequences. Landes Bioscience, Austin, TX.
16. Domingo, E., M. Davila, and J. Ortin. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11:333-346.
17. Domingo, E., et al. 2010. Mutation, quasispecies and lethal mutagenesis, p. 197-211. In E. Ehrenfeld, E. Domingo, and R. P. Roos (ed.), The picornaviruses. ASM Press, Washington, DC.
18. Domingo, E., and S. Wain-Hobson. 2009. The 30th anniversary of quasispecies. Meeting on 'Quasispecies: Past, Present and Future.' EMBO Rep. 10:444-448.
19. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96:13910-13913.
20. Eigen, M. 2002. Error catastrophe and antiviral strategy. Proc. Natl. Acad. Sci. U. S. A. 99:13374-13376.
21. Escarmís, C., et al. 1996. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264:255-267.
22. Escarmís, C., E. Lazaro, A. Arias, and E. Domingo. 2008. Repeated bottleneck transfers can lead to non-cytocidal forms of a cytopathic virus: implications for viral extinction. J. Mol. Biol. 376:367-379.
23. Escarmis, C., C. Perales, and E. Domingo. 2009. Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. J. Virol. 83:6748-6756.
24. Fan, J., et al. 2010. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J. Virol. 84:7278-7287.
25. Feng, D. F., and R. F. Doolittle. 1996. Progressive alignment of amino acid sequences and construction of phylogenetic trees from them. Methods Enzymol. 266:368-382.
26. Ferrer-Orta, C., et al. 2004. Structure of foot-and-mouth disease virus RNAdependent RNA polymerase and its complex with a template-primer RNA. J. Biol. Chem. 279:47212-47221.
27. Garcia-Arriaza, J., E. Domingo, and C. Briones. 2007. Characterization of minority subpopulations in the mutant spectrum of HIV-1 quasispecies by successive specific amplifications. Virus Res. 129:123-134.
28. García-Arriaza, J., S. C. Manrubia, M. Toja, E. Domingo, and C. Escarmís. 2004. Evolutionary transition toward defective RNAs that are infectious by complementation. J. Virol. 78:11678-11685.
29. Gonzalez, M. C., et al. 2009. Human APOBEC1 cytidine deaminase edits HBV DNA. Retrovirology 6:96.
30. González-López, C., A. Arias, N. Pariente, G. Gómez-Mariano, and E. Domingo. 2004. Preextinction viral RNA can interfere with infectivity. J. Virol. 78:3319-3324.
31. González-López, C., G. Gómez-Mariano, C. Escarmís, and E. Domingo. 2005. Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect. Genet. Evol. 5:366-374.
32. Graci, J. D., and C. E. Cameron. 2008. Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol. 3:553-566.
33. Grande-Pérez, A., G. Gómez-Mariano, P. R. Lowenstein, and E. Domingo. 2005. Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J. Virol. 79:10451-10459.
34. Grande-Pérez, A., E. Lazaro, P. Lowenstein, E. Domingo, and S. C. Manrubia. 2005. Suppression of viral infectivity through lethal defection. Proc. Natl. Acad. Sci. U. S. A. 102:4448-4452.
35. Havlir, D. V., S. Eastman, A. Gamst, and D. D. Richman. 1996. Nevirapineresistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70:7894-7899.
36. Henry, M., et al. 2009. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One 4:e4277.
37. Holland, J. J., E. Domingo, J. C. de la Torre, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:3960-3962.
38. Iranzo, J., and S. C. Manrubia. 2009. Stochastic extinction of viral infectivity through the action of defectors. Europhysics Lett. 85:18001.
39. Johnson, J. A., et al. 2008. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Med. 5:e158.
40. Kuntzen, T., et al. 2008. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients. Hepatology 48:1769-1778.
41. Lauring, A. S., and R. Andino. 2011. Exploring the fitness landscape of an RNA virus by using a universal barcode microarray. J. Virol. 85:3780-3791.
42. Lech, W. J., et al. 1996. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J. Virol. 70:2038-2043.
43. Levi, L. I., et al. 2010. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog. 6:e1001163.
44. Martin, V., D. Abia, E. Domingo, and A. Grande-Perez. 2010. An interfering activity against lymphocytic choriomeningitis virus replication associated with enhanced mutagenesis. J. Gen. Virol. 91:990-1003.
45. Mas, A., C. Lopez-Galindez, I. Cacho, J. Gomez, and M. A. Martinez. 2010. Unfinished stories on viral quasispecies and Darwinian views of evolution. J. Mol. Biol. 397:865-877.
46. Nájera, I., et al. 1995. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
47. Nunez, J. I., et al. 2007. Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host. J. Virol. 81:8497-8506.
48. Ochoa, G. 2006. Error thresholds in genetic algorithms. Evol. Comput. 14: 157-182.
49. Ojosnegros, S., et al. 2008. Topology of evolving, mutagenized viral populations: quasispecies expansion, compression, and operation of negative selection. BMC Evol. Biol. 8:207.
50. Ojosnegros, S., et al. 2010. Competition-colonization dynamics in an RNA virus. Proc. Natl. Acad. Sci. U. S. A. 107:2108-2112.
51. Ojosnegros, S., et al. 2011. Viral genome segmentation can result from a trade-off between genetic content and particle stability. PLoS Genet. 7:e1001344.
52. Pariente, N., A. Airaksinen, and E. Domingo. 2003. Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol. 77:7131-7138.
53. Pariente, N., S. Sierra, P. R. Lowenstein, and E. Domingo. 2001. Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J. Virol. 75:9723-9730.
54. Perales, C., R. Agudo, and E. Domingo. 2009. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS One 4:e5554.
55. Perales, C., R. Agudo, S. C. Manrubia, and E. Domingo. 2011. Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus. J. Mol. Biol. 407:60-78.
56. Perales, C., R. Agudo, H. Tejero, S. C. Manrubia, and E. Domingo. 2009. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS Pathog. 5:e1000658.
57. Perales, C., R. Lorenzo-Redondo, C. López-Galíndez, M. A. Martínez, and E. Domingo. 2010. Mutant spectra in virus behavior. Future Virol. 5:679-698.
58. Perales, C., R. Mateo, M. G. Mateu, and E. Domingo. 2007. Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J. Mol. Biol. 369:985-1000.
59. Petit, V., et al. 2009. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 385:65-78.
60. Pfeiffer, J. K., and K. Kirkegaard. 2003. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 100:7289-7294.
61. Renard, M., M. Henry, D. Guétard, J. P. Vartanian, and S. Wain-Hobson. 2010. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. J. Mol. Biol. 400:323-334.
62. Sarrazin, C., and S. Zeuzem. 2010. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138:447-462.
63. Schuster, P., and P. Stadler. 2008. Early replicons: origin and evolution, p. 1-41. In E. Domingo, C. Parrish, and J. J. Holland (ed.), Origin and evolution of viruses. Elsevier, Philadelphia, PA.
64. Sierra, M., et al. 2007. Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J. Virol. 81:2012-2024.
65. Sierra, S., M. Dávila, P. R. Lowenstein, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323.
66. Sobrino, F., M. Dávila, J. Ortín, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310-318.
67. Summers, J., and S. Litwin. 2006. Examining the theory of error catastrophe. J. Virol. 80:20-26.
68. Suspène, R., et al. 2011. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. U. S. A. 108:4858-4863.
69. Suspène, R., et al. 2005. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:8321-8326.
70. Suspène, R., M. Henry, S. Guillot, S. Wain-Hobson, and J. P. Vartanian. 2005. Recovery of APOBEC3-edited human immunodeficiency virus G3A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 86:125-129.
71. Takeuchi, N., and P. Hogeweg. 2007. Error-threshold exists in fitness landscapes with lethal mutants. BMC Evol. Biol. 7:15. (Letter.)
72. Toja, M., C. Escarmis, and E. Domingo. 1999. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res. 64:161-171.
73. Vartanian, J. P., D. Guétard, M. Henry, and S. Wain-Hobson. 2008. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320:230-233.
74. Vartanian, J. P., et al. 2010. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog. 6:e1000928.
75. Vignuzzi, M., J. K. Stone, J. J. Arnold, C. E. Cameron, and R. Andino. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
76. Webster, D. R., et al. 2009. An enhanced single base extension technique for the analysis of complex viral populations. PLoS One 4:e7453.
77. Wright, C. F., et al. 2011. Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J. Virol. 85:2266-2275.
78. Zagordi, O., R. Klein, M. Daumer, and N. Beerenwinkel. 2010. Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res. 38:7400-7409.